Literatur
- 1
Melo J V, Catovsky D, Gregory W M, Galton D A.
The relationship
between chronic lymphocytic leukaemia and prolymphocytic leukaemia.
IV. Analysis of survival and prognostic features.
Br J
Haematol.
1987;
65
23-29
- 2
Montserrat E, Rozman C.
Chronic lymphocytic leukaemia:
prognostic factors and natural history.
Baillieres Clin
Haematol.
1993;
6
849-866
- 3
Hallek M, Kuhn-Hallek I, Emmerich B.
Prognostic factors
in chronic lymphocytic leukemia.
Leukemia.
1997;
11
S4-S13
(Suppl 2)
- 4
Hallek M, Langenmayer I, Nerl C, Knauf W U, Dietzfelbinger H, Adorf D, Ostwald M,
Busch R, Kuhn-Hallek M, Thiel E, Emmerich B.
Elevated serum thymidine
kinase levels identify a subgroup at high risk of disease-progression in
early, non-smoldering chronic lymphocytic leukemia.
Blood.
1999;
93
1732-1737
- 5
Rozman C, Montserrat E.
Chronic
lymphocytic leukemia.
N Engl J Med.
1995;
333
1052-1057
- 6
Vallespi T, Montserrat E, Sanz M A.
Chronic lymphocytic
leukaemia: prognostic value of lymphocyte morphological subtypes.
A multivariate survival analysis in 146 patients.
Br J Haematol.
1991;
77
478-485
Priv.-Doz. Dr. Michael Hallek
Medizinische Klinik und Poliklinik III, Klinikum
Großhadern
Marchioninistraße 15
81366 München
